Address: General del Canto 421 – 6th Floor Providencia, Santiago de Chile
Tel: 5623275010
Web: http://www.boehringer-ingelheim.com/
Boehringer Ingelheim is a group of companies dedicated to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. It is one of the world’s 20 leading pharmaceutical companies. In 2009 it had 142 affiliated companies in 47 countries employing 41,534 employees and with net sales of EUR 12,721 million.
The corporate vision of the company is given by one single phrase: ‘Value through Innovation’. The company was founded in Ingelheim am Rhein (Germany) in 1885, where the corporate headquarters is still located.
The business is divided into the following business areas: Human Pharmaceuticals, Prescription Medicines, Consumer Health Care, Industrial Customer, Biopharmaceuticals, Pharmaceuticals Production, Pharma Chemicals and Animal Health, the largest one being Prescription medicines, where 21% of the net sales is spent in R&D.
Boehringer Ingelheim Chile acts as a distributor of the company’s products in the local market. Supply for the Chilean market is provided by the company’s manufacturing plants in Brazil, Argentina, Colombia and Mexico. Nevertheless, Boehringer Ingelheim conducts several clinical trials in Chile.
Respiratory diseases, Cardiometabolic diseases, Oncology, Neurological diseases, Immunology, Infectious diseases
What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a solid evolution in terms…
Korean biotech SK Bioscience, known for bringing forward the first South Korean-developed COVID-19 vaccine, is pursuing its beyond-COVID growth strategy with a new green light for its SKYCellflu vaccine. The…
Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera has announced a wave of reforms to address inequalities and improve treatment within the country’s healthcare system.…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
Although Chile is a relatively small market, with only 17 million inhabitants, its geography makes it a challenging environment for logistics and distribution services. Chile stretches over 4,300 km along…
Chile is aiming to achieve complete bioequivalence of generics by the end of 2014. Chile’s Public Health Institute is leading the bioequivalence testing, aimed at regulating differences between generic and…
Elmer Torres Cortes is General Manager of the Industrial Association of Pharmaceutical Laboratories (ASILFA) that was created to defend the interests of the generic and local manufacturers. Cortes speaks about…
“Clinica Alemana’s objective is to be the most patient-centric clinic and we take that very seriously. Therefore, we constantly strive to provide the most modern technology, the best infrastructure and,…
Deutsche Pharma’s general manager, Luis Aguilera, speaks about the company’s long family history and growth ambitions t. Deutsche Pharma commercializes its own brands and acts as distributor, supplying the local…
“A company active in the Chilean pharmaceutical market has to reinvent its business model every three years because today we are competing against some of the largest multinationals.” How…
When Antonio Avila came to Chile in 2011, one of his main goals was to adapt the business model to the current needs of the market. The General Manager of…
The global pharmaceutical sector continues to witness significant mergers and acquisitions activity, with 122 M&A deals completed in 2013. This trend has continued due to several multi-billion dollar deals around the…
Chile witnessed increasing demand for vitamin and dietary supplements as a result of improvement of disposable incomes and living standards. Gerardo Sanchez saw an opportunity in this nice and established…
See our Cookie Privacy Policy Here